Wai Chun Bio-Technology (HKSE:00660) Research & Development: HK$0.0 Mil (TTM As of Dec. 2025)


HKSE:00660 Wai Chun Bio-Technology Ltd HKSE:00660
17 GF Score
Price HK$0.48
GF Value HK$0.13
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Wai Chun Bio-Technology Research & Development?

Wai Chun Bio-Technology HKSE:00660 -4.00% 17 Research & Development is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:00660 with a GF Score™ of 17/100 and a GF Value™ of HK$0.13 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Wai Chun Bio-Technology's Research & Development for the six months ended in Dec. 2025 was HK$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.0 Mil.

Wai Chun Bio-Technology  (HKSE:00660) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Wai Chun Bio-Technology Research & Development Related Terms

Wai Chun Bio-Technology Research & Development Historical Data

* Premium members only.

The historical data trend for Wai Chun Bio-Technology's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wai Chun Bio-Technology Research & Development Chart

Wai Chun Bio-Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Wai Chun Bio-Technology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:00660
17GF Score
Wai Chun Bio-Technology Ltd HKSE:00660
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wai Chun Bio-Technology Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$0.0 Mil mean?
Wai Chun Bio-Technology (HKSE:00660) has a Research & Development of HK$0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Wai Chun Bio-Technology and its competitors.
Is Wai Chun Bio-Technology's Research & Development too high?
Wai Chun Bio-Technology's current Research & Development is HK$0.0 Mil. Overall, Wai Chun Bio-Technology has a GF Score™ of 17/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wai Chun Bio-Technology's Research & Development compare to DOW?
Wai Chun Bio-Technology's Research & Development of HK$0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Wai Chun Bio-Technology and its competitors. Wai Chun Bio-Technology's current Research & Development is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wai Chun Bio-Technology stock overvalued right now?
Based on GuruFocus' analysis, Wai Chun Bio-Technology (HKSE:00660) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.13, compared to a current price of HK$0.48 — trading 269.2% above its estimated fair value. The current Research & Development is HK$0.0 Mil. Wai Chun Bio-Technology's overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Wai Chun Bio-Technology (HKSE:00660), the current Research & Development is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wai Chun Bio-Technology (HKSE:00660) Overvalued in 2026?

Based on GuruFocus' analysis, Wai Chun Bio-Technology stock appears to be overvalued. The current stock price of HK$0.48 is trading 269.2% above its estimated GF Value™ of HK$0.13. GuruFocus considers Wai Chun Bio-Technology to be Significantly Overvalued.

Key valuation signals for HKSE:00660:

  • Research & Development: HK$0.0 Mil
  • GF Value™: HK$0.13 vs. price of HK$0.48 (269.2% above fair value)
  • GF Score™: 17/100 with 7 warning signs

No single metric tells the full story. See the HKSE:00660 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wai Chun Bio-Technology Business Description

Address 26 Harbour Road, Rooms 4001-02, 40th Floor, China Resources Building, Wanchai, Hong Kong, HKG
Wai Chun Bio-Technology Ltd is an investment holding company. The company has one reportable segmentbeing the manufacturing and sale of modified starch and other biochemical products. It is involved in the manufacturing and sale of modified starch and other biochemical products. Geographically, it derives a majority of its revenue from the People's Republic of China. The company also has its presence in Hong Kong.
17GF Score

Get the complete analysis for HKSE:00660

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.48
Price
HK$0.13
GF Value